Chairman Gives Talk on Smartphone Origin

Spencer Trask & Co Chairman Kevin Kimberlin Gives Presentation on the Origin of First Pocket Sized Cell Phone

OLD GREENWICH, Conn., PRNewswire/ — Spencer Trask & Co., a privately held advanced technology development firm, today released a presentation that its Chairman Kevin Kimberlin gave in conjunction with this year’s Mobile World Congress Americas event in held San Francisco.

As the new iPhone X was being unveiled in nearby Cupertino, Kevin Kimberlin spoke about “some of the shoulders Steve Jobs stood on” when launching the iPhone, considered by many to be the most popular consumer product ever introduced.

Kimberlin detailed his experience working with Millicom and Jan Stenbeck to make practical two tipping points that launched the smartphone revolution: the pocket-sized portable cellular phone–which set a standard for the shape, form and size of mobile phones for 30 years– and the first cellular network to carry data via text message.

“When I discovered Millicom in 1982 and saw the mocked-up prototype of a consumer-friendly, portable cellular phone, I calculated the market need,” said Kimberlin. “People may not realize that only approximately 8% of the people in the world had a landline telephone in 1982; that’s why I saw the cell phone as the phone for the rest of the world.”

The full video and transcript of Kimberlin’s presentation are available online at www.smartphoneorigin.com.

Kimberlin also participated in a panel discussion at Mobile World Congress Americas where he discussed the evolution of mobile technology and the future of IOT.

About Spencer Trask & Co.

Spencer Trask & Co. is a privately held advanced technology development firm helping entrepreneurs, CEOs and corporate partners start and grow high impact ventures that change the world. The company has been instrumental in helping companies pioneer many technological and scientific advancements in the fields of genomics, healthcare technology, mobile technology, the Internet and Open Innovation. Please visit www.spencertraskco.com for more information.

Immune Response Corporation

Pioneering the vaccine revolution

Developing new vaccines to fight AIDS and cancer

The first FDA-approved cancer vaccine, an immune therapy made from the patient’s own cells.

Polio vaccine hero Dr. Jonas Salk and our Chairman founded The Immune Response Corporation. They recruited the team, attracted $350 million from investors and corporate partners, and developed groundbreaking immune therapies.

IRC technology was key to the first FDA-approved cancer vaccine, sipuleucel-T. More than 40,000 patients have received this prostate cancer therapy, which appears to be more effective in African American men, with a 48% percent reduction in death, compared to white men. The first cell-based immunotherapy, this approval opened the floodgates for immunotherapeutics, today the largest category of pharmaceuticals.